HK1007333A1 - Variants of plasminogen activatos and processes for their production - Google Patents

Variants of plasminogen activatos and processes for their production

Info

Publication number
HK1007333A1
HK1007333A1 HK98106555A HK98106555A HK1007333A1 HK 1007333 A1 HK1007333 A1 HK 1007333A1 HK 98106555 A HK98106555 A HK 98106555A HK 98106555 A HK98106555 A HK 98106555A HK 1007333 A1 HK1007333 A1 HK 1007333A1
Authority
HK
Hong Kong
Prior art keywords
variants
plasminogen
activatos
processes
production
Prior art date
Application number
HK98106555A
Other languages
English (en)
Inventor
Stephen Anderson
Bruce Keyt
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of HK1007333A1 publication Critical patent/HK1007333A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • C12N9/6459Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21069Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK98106555A 1988-05-20 1998-06-25 Variants of plasminogen activatos and processes for their production HK1007333A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19690988A 1988-05-20 1988-05-20
PCT/US1989/001947 WO1989011531A1 (en) 1988-05-20 1989-05-04 Variants of plasminogen activators and processes for their production

Publications (1)

Publication Number Publication Date
HK1007333A1 true HK1007333A1 (en) 1999-04-09

Family

ID=22727245

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98106555A HK1007333A1 (en) 1988-05-20 1998-06-25 Variants of plasminogen activatos and processes for their production

Country Status (12)

Country Link
EP (1) EP0424405B1 (de)
JP (1) JP2928798B2 (de)
AT (1) ATE111525T1 (de)
AU (1) AU624158B2 (de)
CA (1) CA1341432C (de)
DE (1) DE68918279T2 (de)
DK (1) DK175938B1 (de)
ES (1) ES2013500A6 (de)
HK (1) HK1007333A1 (de)
IL (1) IL90146A (de)
NZ (1) NZ229081A (de)
WO (1) WO1989011531A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098840A (en) * 1986-07-03 1992-03-24 The Green Cross Corporation Human prourokinase mutants
US5218092A (en) * 1988-09-29 1993-06-08 Kyowa Hakko Kogyo Co., Ltd. Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains
NO894967L (no) * 1988-12-12 1990-06-13 Yamanouchi Pharma Co Ltd Fremgangsmaate for fremstilling av nye thrombolytiske proteiner.
JPH0387180A (ja) * 1989-05-18 1991-04-11 Green Cross Corp:The 変異ヒトプロウロキナーゼ、その製法、dna配列、プラスミド、宿主
JP3126381B2 (ja) * 1990-07-31 2001-01-22 ジェネンテク,インコーポレイテッド 減少されたクリアランスを有する組織プラスミノーゲンアクチベーター変異体
US5246850A (en) * 1990-07-31 1993-09-21 Genentech, Inc. DNA molecules encoding human tissue plasminogen activator variants with decreased clearance, vectors, and host cells
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
US5595736A (en) * 1991-04-22 1997-01-21 Eli Lilly And Company Compounds and methods for treatment of thromboembolic disorders
US5223408A (en) * 1991-07-11 1993-06-29 Genentech, Inc. Method for making variant secreted proteins with altered properties
ATE155816T1 (de) * 1992-06-03 1997-08-15 Genentech Inc Varianten des gewebeplasminogenaktivators mit verbesserter therapeutischer wirkung
US5945432A (en) * 1995-12-22 1999-08-31 The University Of Vermont And State Agricultural College Thrombolytic agents and thienopyridine derivatives in acute stroke
US7553930B2 (en) 2003-01-06 2009-06-30 Xencor, Inc. BAFF variants and methods thereof
CA2553257A1 (en) * 2004-01-14 2005-08-04 Ohio University Methods of producing peptides/proteins in plants and peptides/proteins produced thereby

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8528321D0 (en) * 1985-11-18 1985-12-24 Ciba Geigy Ag Modified fibrinolytic agents
ZA869626B (en) * 1985-12-23 1987-10-28 Chiron Corp Peptide plasminogen activators
DK43387A (da) * 1986-01-29 1987-07-30 Beecham Group Plc Fibrinolytisk enzym
AU7090787A (en) * 1986-02-19 1987-10-08 Beecham Group Plc Tissue plasminogen activator
IE81073B1 (en) * 1986-03-18 2000-01-12 Genentech Inc Modified human tissue-type plasminogen activator and its preparation

Also Published As

Publication number Publication date
WO1989011531A1 (en) 1989-11-30
DK274990A (da) 1991-01-18
ES2013500A6 (es) 1990-05-01
ATE111525T1 (de) 1994-09-15
JPH03504327A (ja) 1991-09-26
IL90146A0 (en) 1989-12-15
CA1341432C (en) 2003-06-17
JP2928798B2 (ja) 1999-08-03
EP0424405A1 (de) 1991-05-02
EP0424405B1 (de) 1994-09-14
DK175938B1 (da) 2005-07-25
NZ229081A (en) 1991-03-26
AU624158B2 (en) 1992-06-04
DE68918279T2 (de) 1995-03-23
IL90146A (en) 1994-10-07
AU3744889A (en) 1989-12-12
DK274990D0 (da) 1990-11-19
DE68918279D1 (de) 1994-10-20

Similar Documents

Publication Publication Date Title
PH24857A (en) Recombinant human endothelial cell growth factor
HK1007333A1 (en) Variants of plasminogen activatos and processes for their production
FI875533A (fi) Insulinpreparat foer non-parenteral dosering.
SE8902638L (sv) Stabiliserade protein- eller peptidkonjugat
ZA90861B (en) Derivative of tissue-type plasminogen activator
PT80300A (de) Herstellung von polypeptiden mit human-gammainterferonaktivitat
KR900002795A (ko) 하이브리드 단백질c 작제물 및 그들의 제조방법
ES2037136T3 (es) Procedimiento para la preparacion de una solucion con elevada actividad volumetrica de una proteina con actividad de activador de plasminogeno de tejidos (t-pa).
EP0315118A3 (de) Endothelin kodierendes DNA und dessen Verwendung
PT83939A (en) Method for the production of human placenta angiogenic factor capable of stimulating capillary endothelial cell protease synthesis dna synthesis and migration
DE69113049D1 (de) Varianten des gewebeplasminogenaktivators mit vermindertem abbau.
EP0386240A4 (en) Novel polypeptide compounds
GR3015094T3 (en) Tissue plasminogen activator substitution variant.
KR870008588A (ko) 신규 인체 조직형 플라스미노겐 활성제 폴리펩티드

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20090503